Q2 EPS Estimates for Co-Diagnostics Raised by HC Wainwright
Co-Diagnostics, Inc. (NASDAQ:CODX – Free Report) – Investment analysts at HC Wainwright increased their Q2 2025 earnings per share (EPS) estimates for Co-Diagnostics in a note issued to investors on Monday, May 12th. HC Wainwright analyst Y. Chen now expects that the company will post earnings per share of ($0.25) for the quarter, up from […]
